Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
ELV Stock Chart & Stats
$291.45
<$0.01(<0.01%)
At close: 4:00 PM EST
$291.45
<$0.01(<0.01%)
Day’s Range― - ―
52-Week Range$273.71 - $458.75
Previous CloseN/A
Volume477.50K
Average Volume (3M)1.93M
Market Cap
$64.32B
Enterprise Value$88.15B
Total Cash (Recent Filing)$9.49B
Total Debt (Recent Filing)$33.23B
Price to Earnings (P/E)13.7
Beta0.27
Next Earnings
Apr 22, 2026EPS Estimate
10.62Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)3.33
Shares Outstanding220,704,670
10 Day Avg. Volume1,871,905
30 Day Avg. Volume1,927,336
Financial Highlights & Ratios
PEG Ratio-5.63
Price to Book (P/B)1.77
Price to Sales (P/S)0.39
P/FCF Ratio24.50
Enterprise Value/Market Cap1.37
Enterprise Value/Revenue0.44
Enterprise Value/Gross Profit1.73
Enterprise Value/Ebitda9.13
Forecast
1Y Price Target
$389.07Price Target Upside33.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)25.99
Revenue Forecast (FY)$194.93B
Bulls Say, Bears Say
Bulls Say
Business Segment GrowthIncreased investment in the Carelon unit and strong external business growth point to diversified revenue streams that could lift overall profitability as scale expands.
Earnings QualityA favorable tax outcome contributed to an earnings beat, supporting near-term cash flow while management works to contain administrative costs.
GuidanceAnalyst's view that management issued conservative earnings guidance establishes a cautious baseline that could allow upside if margins normalize.
Bears Say
Medicaid PerformanceShrinking Medicaid enrollment and persistent negative Medicaid margins create uncertainty about the company's ability to deliver steady earnings from public programs.
Medicare Advantage ReimbursementDeclining Medicare Advantage reimbursement rates are expected to pressure margins and reduce projected earnings unless reimbursement trends reverse.
Membership AttritionProjected declines in Medicare Advantage and exchange memberships, coupled with deliberate pricing actions that reduce enrollment, threaten membership-driven revenue and could weigh on top-line growth.
Elevance Health News
ELV FAQ
What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was $273.71 and its highest was $458.75 in the past 12 months.
What is Elevance Health’s market cap?
Elevance Health’s market cap is $64.32B.
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Apr 22, 2026 which is in 48 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Jan 28, 2026. The company reported $3.33 earnings per share for the quarter, beating the consensus estimate of $3.096 by $0.234.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.71 which represents an annual dividend yield of 1.99%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is 10.62.
How many shares outstanding does Elevance Health have?
Elevance Health has 220,704,670 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $3.33 in its last earnings report, beating expectations of $3.096. Following the earnings report the stock price went up 5.862%.
Which hedge fund is a major shareholder of Elevance Health?
Currently, no hedge funds are holding shares in ELV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Elevance Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$389.07 (33.49% Upside)
$389.07 (33.49% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 92%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 895.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 3.6%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
News Sentiment
Bearish
Bullish news 20%
Bearish news 80%
Bearish news 80%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.79%
12-Months-Change
Fundamentals
Return on Equity
13.29%
Trailing 12-Months
Asset Growth
3.94%
Trailing 12-Months
Company Description
Elevance Health
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
ELV Company Deck
ELV Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced significant near-term challenges—notably membership declines (Medicaid and Medicare), elevated cost trends, a negative Medicaid margin expectation for 2026, and a lower 2026 EPS baseline versus 2025—with several constructive positives: strong Q4 revenue, Carillon growth and external demand, disciplined pricing and portfolio repositioning, targeted investments in analytics and care management, healthy ASO sales momentum, and a clear plan to return to at least 12% EPS growth in 2027. Management emphasized prudent assumptions and execution, but material near-term headwinds and margin recalibrations reduce upside in 2026.View all ELV earnings summariesELV Stock 12 Month Forecast
Average Price Target
$389.07
▲(33.49% Upside)
Technical Analysis
Ownership Overview
0.14% Insiders
27.17% Mutual Funds
11.04% Other Institutional Investors
37.95% Public Companies and Individual Investors